PROGENICS PHARMACEUTICALS IN - COM (PGNX)

CUSIP: 743187106

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
60,301,771
Share change
+1,328,379
Total reported value
$381,807,850
Put/Call ratio
43%
Price per share
$6.33
Number of holders
111
Value change
+$9,633,606
Number of buys
61
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 743187106?
CUSIP 743187106 identifies PGNX - PROGENICS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROGENICS PHARMACEUTICALS IN - COM (PGNX) as of Q3 2016

As of 30 Sep 2016, PROGENICS PHARMACEUTICALS IN - COM (PGNX) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,301,771 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, FMR LLC, BlackRock Fund Advisors, PINNACLE ASSOCIATES LTD, VANGUARD GROUP INC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 111 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.